Filing Flows › Bio Key International (BKYI) › Q3 2025
Bio Key International (BKYI) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 14, 2025
Bio Key International (BKYI) reported revenue of $1.5M for the third quarter 2025 (Q3 2025), -28% from a year earlier and -9% from the quarter before. Operating margin was -57.6%, net loss $965K (62.3% of revenue).
Bio Key International, Q3 2025: revenue $1.5M (-28% year over year), operating margin -57.6%, net loss $965K, operating cash flow −$1.1M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.5M | -9% | -28% |
| Operating profit | −$892K | — | — |
| Net earnings | −$965K | — | — |
| Operating cash flow | −$1.1M | — | — |
What changed
Revenue was $1.5M in Q3 2025, down 28% year over year and down 9% from the previous quarter. License was the largest line at 59% of revenue. License lost $523K year over year (down 36%), 88% of the total change.
Gross margin was 76.9%, down 1.4 points from a year earlier. Operating costs exceeded revenue by $892K, an operating margin of -57.6%. Operating expenses fell 8% while revenue fell 28%. The quarter ended with a net loss of $1.0M, narrower than the previous quarter's $1.2M loss.
Operating cash flow was −$1.1M. Non-cash charges added back $78K of depreciation and amortization and $32K of share-based compensation. Working capital and other items used $267K. Capital expenditures of $1K exceeded it, leaving free cash flow of −$1.1M.
Questions
What was Bio Key International's revenue in the third quarter 2025?
Bio Key International (BKYI) reported revenue of $1.5M for the third quarter 2025 (Q3 2025), -28% from a year earlier and -9% from the quarter before.
Was Bio Key International profitable in the third quarter 2025?
Operating loss was $892K (-57.6% of revenue) and net loss $965K.